Synergy Pharmaceuticals

5 Small Biotechs Receive Shots in the Arm
5 Small Biotechs Receive Shots in the Arm
TheStreet.com
earnings
Synergy Pharmaceuticals
Omeros
BioDelivery Sciences
Heron Therapeutics
Dynavax
Flag link:
Synergy preps for Trulance launch with competitive pricing, experienced GI reps
Synergy preps for Trulance launch with competitive pricing, experienced GI reps
Fierce Pharma
Synergy Pharmaceuticals
drug launches
Trulance
drug reps
Flag link:
Did 50 Salespeople Leave Valeant? Wells Fargo Investigates
Did 50 Salespeople Leave Valeant? Wells Fargo Investigates
Barron's
Valeant Pharmaceutcals
drug reps
Synergy Pharmaceuticals
plecanatide
Flag link:
Can 'Santa Claus' Rally Continue For These 3 Small Biotechs?
Can 'Santa Claus' Rally Continue For These 3 Small Biotechs?
Seeking Alpha
biotech
Portola
betrixaban
Synergy Pharmaceuticals
plecanatide
Progenics
prostate cancer
Flag link:
All Eyes on These Two Biotech Firms Ahead of FDA Decisions
All Eyes on These Two Biotech Firms Ahead of FDA Decisions
Investopedia
FDA
biotech
MACI
Vericel Corporation
chronic idiopathic constipation
Synergy Pharmaceuticals
plecanatide
Flag link:
Synergy Pharmaceuticals Sinks on FDA Update
Synergy Pharmaceuticals Sinks on FDA Update
24/7 Wall St
Synergy Pharmaceuticals
FDA
chronic idiopathic constipation
IBS-C
plecanatide
Flag link:
3 Plausible Buyout Scenarios Within Biotech
3 Plausible Buyout Scenarios Within Biotech
Seeking Alpha
biotech
Acadia
AstraZeneca
Allergan
Biogen
Teva Pharmaceutical
Biomarin
Incyte
Ironwood
Medivation
Pfizer
Relypsa
Synergy Pharmaceuticals
M&A
Flag link:
3 Risky Biotechs With FDA Decisions On Deck
3 Risky Biotechs With FDA Decisions On Deck
Motley Fool
FDA
Sarepta Therapeutics
eteplirsen
Synergy Pharmaceuticals
plecanatide
Celator
Vyxeos
Flag link:
3 Big Battles Brewing in Biotech
3 Big Battles Brewing in Biotech
Motley Fool
AstraZeneca
ZS-9
Relypsa
Veltassa
Synergy Pharmaceuticals
plecanatide
Linzess
Ironwood
Allergan
Incyte
Eli Lilly
baricitinib
AbbVie
Humira
Flag link:
Is This Ironwood Pharmaceuticals' Biggest Threat?
Is This Ironwood Pharmaceuticals' Biggest Threat?
Motley Fool
Ironwood Pharmaceuticals
Linzess
plecanatide
Synergy Pharmaceuticals
Flag link:
Synergy's Looming FDA Filing Makes It Pharma of the Month
Synergy's Looming FDA Filing Makes It Pharma of the Month
TheStreet.com
Synergy Pharmaceuticals
FDA
plecanatide
Flag link:
4 Key FDA Decisions Expected in November and December
4 Key FDA Decisions Expected in November and December
24/7 Wall St
FDA
Androxal
Repros Therapeutics
elvitegravir
cobicistat
emtricitabine
tenofovir alafenamide
OPuS-2
Biocryst
Synergy Pharmaceuticals
plecanatide
Flag link:
Does Synergy Pharma's Plecanatide Blow Away The Competition?
Does Synergy Pharma's Plecanatide Blow Away The Competition?
Seeking Alpha
Synergy Pharmaceuticals
IBS-C
plecanatide
Linzess
Ironwood
Flag link:
Why This Analyst Sees Synergy Pharma Still Doubling Even After Huge Gains
Why This Analyst Sees Synergy Pharma Still Doubling Even After Huge Gains
24/7 Wall St
Synergy Pharmaceuticals
chronic idiopathic constipation
plecanatide
Flag link:
Synergy soars on stellar constipation data, rekindling buyout chatter
Synergy soars on stellar constipation data, rekindling buyout chatter
Fierce Biotech
Synergy Pharmaceuticals
plecanatide
constipation
M&A
Flag link:
Synergy Pharma Said to Consider Sale Ahead of Trial Results
Synergy Pharma Said to Consider Sale Ahead of Trial Results
Bloomberg
Synergy Pharmaceuticals
M&A
plecanatide
Flag link:
Synergy Pharmaceuticals' plecanatide shows positive results in Phase 2B study
Synergy Pharmaceuticals' plecanatide shows positive results in Phase 2B study
Yahoo/Fly on the Wall
Synergy Pharmaceuticals
plecanatide
IBS-C
Flag link:
Previous Data Signals Positive Phase IIb Results Likely To Come For Synergy Pharmaceuticals
Previous Data Signals Positive Phase IIb Results Likely To Come For Synergy Pharmaceuticals
Seeking Alpha
Synergy Pharmaceuticals
IBS-C
Ironwood Pharmaceuticals
Linzess
Sucampo
plecanatide
Flag link:
Biotechs With Near-Term Catalysts That Should Rally
Biotechs With Near-Term Catalysts That Should Rally
Seeking Alpha
Ampio
Avanir
Chelsea Therapeutics
Endo Health Solutions
Optina
Northera
Synergy Pharmaceuticals
plecanatide
AVP-825
vintafolide
Flag link:
The Best- And Worst-Performing Biotech Stocks, Dec. 19 to Dec. 26
The Best- And Worst-Performing Biotech Stocks, Dec. 19 to Dec. 26
Forbes
biotech
Inovio
United Therapeutics
Synergy Pharmaceuticals
Flag link:

Pages